▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3395 by analyst upside · 2026-11-13
LQDA
Liquidia Corporation
Healthcare · Market Cap $5B · P/E 0x
ANALYST PRICE TARGET
+9.9%
implied upside to consensus target
Current Price $58.12
Consensus Target $63.88
Bull Target $87.0
Bear Target $33.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
2
Sell
0
52-Week Low $22.31
52-Week High $93.61
YTD Return +85.1%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) N/A
Forward P/E 16.9x
EPS (TTM) $-1.05
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $622M
Profit Margin -15.1%
52-WEEK RANGE
52-Week Low $22.31
52-Week High $93.61
Current Price $58.12
Bear Target $33.0
Bull Target $87.0
● Now $58.12 ● Target $63.88
TRADING DATA
Avg Volume 3.5M
YTD Return +85.1%
Analyst Count 8
Consensus Buy
Upside to Target +9.9%
Last Updated 2026-11-13

ANALYST SUMMARY

Liquidia Corporation (LQDA) is currently trading at $58.12 with a Wall Street consensus price target of $63.88, implying potential upside of 9.9% over the next 12 months. 8 analysts currently cover LQDA, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $87.0, while the most cautious has a target of $33.0.

LQDA operates in the Healthcare sector with a market capitalisation of $5B. The stock is up 85.1% year-to-date and is currently trading near the upper end of its 52-week range of $22.31 – $93.61.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for LQDA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. - Reiterated
Buy → Buy 2026-10-15 31% win rate (48 calls)
LifeSci Capital ↑ Upgrade
Market Perform → Outperform 2026-10-14 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-10-14 Building track record
Needham - Reiterated
Buy → Buy 2026-10-14 20% win rate (5 calls)
BTIG ↑ Upgrade
Neutral → Buy 2026-10-14 38% win rate (8 calls)
Wells Fargo ↓ Downgrade
Overweight → Equal-Weight 2026-10-02 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-10-02 31% win rate (48 calls)
Raymond James ↓ Downgrade
Strong Buy → Outperform 2026-10-01 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
17/30
Consensus clarity
11/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →